Ruogang Zhao, Jianhao Liu, Zhaohuan Li, Wenhui Zhang, Feng Wang, & Bo Zhang. (2022). Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. MDPI AG.
Chicago Style (17th ed.) CitationRuogang Zhao, Jianhao Liu, Zhaohuan Li, Wenhui Zhang, Feng Wang, and Bo Zhang. Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. MDPI AG, 2022.
MLA (9th ed.) CitationRuogang Zhao, et al. Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.